Premium
IgG anti‐Jk a /Jk b antibodies are unlikely to fix complement
Author(s) -
Yates,
Howell,
Overfield,
Adam Voak,
Downie,
' Austin
Publication year - 1998
Publication title -
transfusion medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.471
H-Index - 59
eISSN - 1365-3148
pISSN - 0958-7578
DOI - 10.1046/j.1365-3148.1998.00139.x
Subject(s) - complement (music) , antibody , medicine , immunology , chemistry , biochemistry , complementation , gene , phenotype
Antibodies in the Kidd blood group system show a great deal of serological variability, are notoriously elusive and hence evoke difficulties in detection. However, they have been regularly reported as causing severe immediate or delayed haemolytic transfusion reactions and this clinical potential has been largely attributed to their complement binding ability. In initial investigations on 43 anti‐Jk a /Jk b sera with a range of titres of IgG antibody only a few seemed to fix complement, though following repeated tests on 20 of these sera a further five were shown to bind complement, making a total of 12 (27.9%) showing evidence of complement binding. Twenty‐three sera were unavailable for re‐testing. Subsequent tests revealed that only those sera which showed direct agglutination or were positive with an anti‐IgM reagent in an indirect antiglobulin test (IAT) fixed complement. Evaluations on the IgG fractions of six selected potent anti‐Jk a sera failed to reveal any complement‐fixing ability although all the original sera bound complement avidly and contained variable amounts of IgM antibody, some at very low subagglutinating levels. These findings challenge past perceptions and give cause for reflection on the changing methodologies and strategies which could unduly compromise the detection of these potentially clinically damaging antibodies.